Elizabeth A Heller, PhD

faculty photo
Associate Professor of Pharmacology
Member, Penn Epigenetics Institute
Department: Systems Pharmacology and Translational Therapeutics

Contact information
3400 Civic Center Boulevard
SCTR 10-115 Smilow
Philadelphia, PA 19104
Education:
HS
Stuyvesant High School, 1998.
BA (Biology)
University of Pennsylvania, 2002.
PhD (Molecular Biology)
The Rockefeller University, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

The Heller Lab studies the mechanisms by which epigenome remodeling regulates neuronal gene function and behavior. To approach this problem, we directly manipulate histone and DNA modifications at specific genes in vivo, using viral delivery of novel epigenetic editing tools, such as zinc-finger transcription factors and CRISPR/dCas9-fusion proteins. We use high-throughput sequencing to identify genes at which drug- or stress-regulation of a known epigenomic signature correlates with changes in expression. We can then target individual modifications and examine their causal relevance to transcriptional regulation and subsequent behavioral adaptations. This ‘bottom-up’ approach allows direct elucidation of the causal relevance of epigenetic remodeling in the brain. Because addiction and depression persist long after cessation of the harmful experience, epigenetic remodeling is an attractive underlying mechanism and presents an intriguing target for therapeutic intervention.

Selected Publications

Bhatnagar A, Heller EA: Alternative splicing in addiction. Current Opinion in Genetics & Development 92, June 2025 Notes: Accepted.

Hokenson RE, Rodríguez-Acevedo KL, Chen Y, Short AK, Samrari SA, Devireddy B, Jensen BJ, Winter JJ, Gall CM, Soma KK, Heller EA, Baram TZ: Unexpected mechanisms of sex-specific memory vulnerabilities to acute traumatic stress. biorxiv doi.org/10.1101/2025.03.25.645300 March 2025.

Quiles CR, Simmons S, Dodson O, Alday M, Fontanez NC, Garrison A, Shafieichaharberoud F, Huang X, Hu Q, Heller EA, Mazei-Robison MS, Caico S: Identification of a novel population of neuromedin S expressing neurons in the ventral tegmental area that promote morphine-elicited behavior. The Journal of Neuroscience February 2025.

Rodgers S, Heller EA, Corder G: Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles. Nature Neuroscience 2025 Notes: Accepted.

Heller EA, Bintu L, Rots MG: Towards clinical application of epigenetic editing. Nature Reviews Drug Discovery 2025 Notes: Invited review, Under revision.

Krick KS, Maroni M, Korb E, Lynch KI, Heller EA: Meta-analysis of activated neurons reveals dynamic regulation of diverse classes of alternative splicing. Genome Research 2025 Notes: Accepted.

Czarnecki KS, Heller EA: A neuronal gene that loops the loop. Science 386(6727): 1223-1224, Dec 2024.

Stein G, Aly JS, Manzolillo A, Lange L, Riege K, Hussain I, Heller EA, Cubillos S, Ernst T, Hübner CA, Turecki G, Hoffman S, Engmann O: Transthyretin Orchestrates Vitamin B12–Induced Stress Resilience. Biological Psychiatry July 2024.

Zhang S, Heil BJ, Mao W, Chikina M, Greene CS, Heller EA: MousiPLIER: A Mouse Pathway-Level Information Extractor Model. eNeuro 11(6), June 2024.

Hamilton PJ, Lim CJ, Nestler EJ, Heller EA: Neuroepigenetic editing. Epigenome Editing: Methods & Protocols. 2nd Ed. Rots MG & Jeltsch A (eds.). 2, April 2024.

back to top
Last updated: 04/21/2025
The Trustees of the University of Pennsylvania